Clinical use of Abemaciclib a cyclin-dependent kinase (CDK) 4/6 inhibitor in patients with breast cancer — literature review

Breast cancer is the most common neoplasma affecting women. Over, the past few years, the incidence of breast cancer has significantly increased, including among young women. Hormone receptor-positive (HR+) Her2 negative (HER2-) early stage breast cancer can be successfully treated using the curren...

Full description

Bibliographic Details

Published in:	Journal of Education, Health and Sport
Main Authors:	Katarzyna Maria Krukar, Martyna Pustelniak, Katarzyna Rudnicka, Ilona Sajkiewicz, Nadia Miga-Orczykowska, Ilona Jasiuk, Justyna Wójtowicz, Paulina Lemieszek, Ewa Łukaszewska, Klaudia Kister, Kamil Chrościński, Jakub Laskowski
Format:	Article
Language:	English
Published:	Kazimierz Wielki University 2024-09-01
Subjects:	Breast cancer abemaciclib CKD 4/6 inhibitor
Online Access:	https://apcz.umk.pl/JEHS/article/view/55282